Urethral Dilators Market size is expected to cross USD 593 Million by the end of 2035, growing at a CAGR of 6% during the forecast period, i.e., 2023 – 2035. In the year 2022, the industry size of Urethral Dilators was USD 218 Million. The reason behind the growth is impelled by the increasing prevalence of chronic kidney disorders. The prevalence of chronic kidney disease (CKD) has been identified as a major global public health issue, which is majorly caused by stress, and hypertension in all high- and middle-income nations.
Chronic kidney diseases can result in various urological conditions, which involve the use of urethral dilators. Chronic kidney disease (CKD) affects more than 8% of people globally, and millions of people pass away each year because they lack access to effective treatment.
The rising popularity of minimally invasive procedures are believed to fuel the market growth. The popularity of minimally invasive surgery among patients has grown owing to its advantages such as smaller incisions, less discomfort, and shorter hospital stay.
Urethral dilation is a minimally invasive procedure for the treatment of bulbar urethral strictures where a permanent catheter is used to drain the bladder, which offers a faster recovery, and minimal scarring.
|
Base Year |
2022 |
|
Forecast Year |
2023-2035 |
|
CAGR |
~6% |
|
Base Year Market Size (2022) |
~ USD 0.218 Billion |
|
Forecast Year Market Size (2035) |
~ USD 0.593 Billion |
|
Regional Scope |
|
Growth Drivers
Challenges
Usage (Reusable, Disposable)
The disposable segment is estimated to gain a robust market share of 62% in the coming years owing to the benefits offered. Disposable urethral dilators are designed for single use with consistent quality standards. They don’t require any sterilization which reduces the risk of cross-contamination between patients. In addition, these dilators are cost-effective as compared to reusable dilators and can be easily disposed of.
Application (Meatal Stenosis, Urethral Stricture, Kidney Stone Removal)
The urethral stricture segment in the urethral dilators market is set to garner a notable share of 51% shortly on the account of growing surgical procedures. Surgical procedures involve the repeated use of catheters which may cause irritation or swelling and scar tissue formation, which can restrict the urethra and cause urine to back up in the urinary tract, resulting in urethral stricture. This can be treated by using the urethral dilation technique where a doctor puts a very little wire into the bladder through the urethra by stretching the urethra's sidewalls. Every year, more than 300 million major surgical procedures are carried out worldwide.
Our in-depth analysis of the global market includes the following segments:
|
Usage |
|
|
Application |
|
|
End-User |
|
|
Type |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this Report
North American Market Forecast
Urethral dilators market in North America is predicted to account for the largest share of 38% by 2035 impelled by the growing spending in healthcare. As a result, more efficient and advanced medical technologies including urethral dilators are expected to develop in the region. In addition, availability of more resources would also improve the medical access, which may result in a higher number of surgeries that may require urethral dilators. In 2021, health spending in the US increased by over 2%.
APAC Market Statistics
The APAC urethral dilators market is estimated to be the second largest, during the forecast timeframe led by rapidly growing medical tourism. India's medical tourism industry is expanding, since there are many different travel choices available in the country such as its low-cost treatments and state-of-the-art medical facilities. This has significantly increased the demand for urethral dilators as people from different regions visit India and other Asia Pacific countries for urological treatments.
For instance, more than a million individuals from over 75 different countries travel to India each year for medical, wellness, and IVF procedures. As a result, the demand for urethral dilators may rise in the region as more people can access medical facilities for the treatment of urological conditions.
Author Credits: Radhika Gupta, Shivam Bhutani
Ans: Increasing prevalence of chronic kidney disorders and the rising popularity of minimally invasive procedures are the major factors driving the growth of the market.
Ans: The market size of Urethral Dilators is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023 – 2035.
Ans: The major players in the market are Enfucell Oy, STMicroelectronics International N.V., LG Chem, Ltd., Cymbet Corporation, Imprint Energy Inc, Jenax Inc., Samsung SDI Co., Ltd., Excellatron Solid State, LLC, and others.
Ans: The disposable segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Ans: The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?